Purchase Order 75F40124P00059

The Department of Health and Human Services Food and Drug Administration awarded a $70,110 firm fixed price purchase order to Ste&P Research LLC, doing business as Seqpal, to sequence 95 genomic DNA samples derived from drug-induced liver injury patients. This supports Protocol E0779001 under the Division of Bioinformatics and Biostatistics to identify genetic and nongenetic factors associated with individual susceptibility. Performance will occur in Jefferson, Arkansas through February 2027. The award was made to a self-certified small disadvantaged business without a set-aside designation. This work will provide genomic sequencing data to aid the FDA's analysis of factors influencing individual responses to drug toxicity as part of its efforts to ensure drug safety.